4,516 followers
Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate #COVID19 📌https://t.co/sZ2m2WdaNo @mdpi 📌https://t.co/zD5pXKfR6N @OUPAcademic 📌 https://t.co/minmUKOnHl @FrontImmunol
Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate #COVID19 📌https://t.co/sZ2m2WdaNo @mdpi 📌https://t.co/zD5pXKfR6N @OUPAcademic 📌 https://t.co/minmUKOnHl @FrontImmunol
New article: Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease https://t.co/XnIqDXqslC #coronavirus #COVID19 #2019ncov https://t.co/g2N22LPk5l